Back to Search
ANIGE'R ORIOL, MD
MD
Internal Medicine Physician
NPI: 1437890712IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
A188975(CA)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 2022
Research & Publications (20)
In vivo quantification of response to treatment in patients with multiple myeloma by 1H magnetic resonance spectroscopy of bone marrow.
PMID 17410391·MAGMA·2007
3-trial
Feasibility and results of autologous stem cell transplantation in de novo acute myeloid leukemia in patients over 60 years old. Results of the CETLAM AML-99 protocol.
PMID 15257930·Haematologica·2004
2-rct
Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial.
PMID 18162120·Br J Haematol·2008
3-trial
High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphoma.
PMID 18223288·Haematologica·2008
3-trial
High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients.
PMID 18457327·Cancer·2008
3-trial
Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.
PMID 18398150·J Clin Oncol·2008
3-trial
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression.
PMID 18322252·Haematologica·2008
3-trial
Comparison of intensive chemotherapy, allogeneic, or autologous stem-cell transplantation as postremission treatment for children with very high risk acute lymphoblastic leukemia: PETHEMA ALL-93 Trial.
PMID 17194902·J Clin Oncol·2007
3-trial
Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit: a single-center experience.
PMID 17483054·Int J Hematol·2007
8-other
Monosomy 7 with severe myelodysplasia developing during imatinib treatment of Philadelphia-positive chronic myeloid leukemia: two cases with a different outcome.
PMID 17563075·Am J Hematol·2007
5-case
Phase II PETHEMA trial of alternating bortezomib and dexamethasone as induction regimen before autologous stem-cell transplantation in younger patients with multiple myeloma: efficacy and clinical implications of tumor response kinetics.
PMID 17785704·J Clin Oncol·2007
3-trial
Advanced stage is the most important prognostic factor for survival in patients with systemic acquired immunodeficiency syndrome-related non-Hodgkin's Lymphoma treated with CHOP and highly active antiretroviral therapy.
PMID 18055341·Int J Hematol·2007
8-other
Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
PMID 17087744·Eur J Haematol·2007
3-trial
[Neutropenic enterocolitis in adult patients with acute leukemia or stem cell transplant recipients: study of 7 cases].
PMID 18005634·Med Clin (Barc)·2007
5-case
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study.
PMID 16772605·Blood·2006
3-trial
[Prognostic influence of immunological subtypes of T-cell acute lymphoblastic leukemia. Study of 81 patients].
PMID 16426542·Med Clin (Barc)·2006
8-other
Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
PMID 16700036·Cancer·2006
8-other
Stability domains, substrate-induced conformational changes, and hinge-bending motions in a psychrophilic phosphoglycerate kinase. A microcalorimetric study.
PMID 16227206·J Biol Chem·2005
8-other
[Neurologic complications following hematopoietic stem cell transplantation. Study of 14 patients].
PMID 16435442·Med Clin (Barc)·2005
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 UCLA MEDICAL PLZ STE 420
LOS ANGELES, CA 90095 - Phone
- (310) 206-6332
Quick Facts
- NPI
- 1437890712
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 4
- Publications
- 20
Are you this provider?
Claim Your Profile